Eosinophil Markers and Development of Disease in Allergic Rhinitis
NCT01192386 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29
Last updated 2010-09-01
Summary
Inflammatory proteins from eosinophil granulocytes in blood from patients with seasonal allergic hayfever have been shown to predict development of asthma at a six-year follow-up. This study is a 15-year follow-up of the same patients to verify earlier results and study disease development.
Conditions
- Seasonal Allergic Rhinitis
Sponsors & Collaborators
-
Aarhus University Hospital
collaborator OTHER -
University of Aarhus
lead OTHER
Principal Investigators
-
Lars Peter Nielsen, MD · Department of Respiratory Research, Aarhus University Hospital, DK-8000 Aarhus C, Denmark
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-05-31
- Primary Completion
- 2010-05-31
- Completion
- 2010-05-31
More Related Trials
-
Systemic Mechanisms in Allergic Rhinitis: Assessment of Metabolomic Outcomes.
NCT02230475 ·Status: COMPLETED
-
Contribution of Nasal IgE Production to the Boost of Systemic Allergen-specific IgE Upon Nasal Allergen Contact
NCT05042830 ·Status: RECRUITING ·Phase: NA
-
Comparison of Perennial and Preseasonal Subcutaneous Immunotherapy
NCT01555736 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Nasal Filters on Seasonal Allergic Rhinitis (Hay Fever)
NCT01699165 ·Status: COMPLETED ·Phase: NA
-
Innate Neutrophilic Nasal Inflammation in a Pollen Exposure Chamber
NCT03496103 ·Status: COMPLETED ·Phase: PHASE1
-
A Single-Center Evaluation of the Pattern of Allergic Signs and Symptoms During 4 Weeks in Ragweed Season
NCT00982163 ·Status: COMPLETED
-
The Role of Th9 Cells and Eosinophils Activity in Allergic Airway Diseases
NCT02214303 ·Status: UNKNOWN
-
The Efficacy of Preseasonal Omalizumab Treatment
NCT04489121 ·Status: COMPLETED ·Phase: NA
-
Exploration Of Key Targets And Biomarkers Involved In An Allergic Response In Subjects With Allergic Rhinitis (Hay Fever)
NCT00348361 ·Status: COMPLETED ·Phase: PHASE1
-
An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269)
NCT00092885 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Hypertonic Solutions on Allergic Rhinitis Patients
NCT02233426 ·Status: UNKNOWN
-
Changes in Adaptive Immune Responses and Effector Cell Responses Upon Nasal Allergen Exposure - a Pilot Study
NCT03644680 ·Status: COMPLETED ·Phase: NA
-
CysLT1-r Expression Following Allergen Exposure in Asthma and Allergic Rhinitis
NCT00631254 ·Status: UNKNOWN ·Phase: NA
-
A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression
NCT00091871 ·Status: RECRUITING
-
Mechanisms of Allergen Immunotherapy
NCT01523158 ·Status: TERMINATED ·Phase: NA
-
Airway Inflammation in Children With Allergic Rhinitis and Intervention
NCT02352168 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Nasal Allergen Challenge Procedure Using Dust Mite Extract
NCT00927329 ·Status: WITHDRAWN ·Phase: PHASE1
-
Evaluation of Nasal Inflammatory Biomarkers
NCT03450031 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study Evaluating the Signs and Symptoms of Seasonal Allergic Rhinoconjunctivitis Following Exposure in the Allergen BioCube
NCT00985075 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergic Rhinitis
NCT06051786 ·Status: COMPLETED ·Phase: PHASE2
-
Dexpramipexole Dose-Ranging Biomarker Study in Subjects With Eosinophilic Asthma
NCT04046939 ·Status: COMPLETED ·Phase: PHASE2
-
Resolution of Allergic Inflammation
NCT01992835 ·Status: COMPLETED ·Phase: NA
-
The Effects of Using Yupingfeng Powder with Variation for the Treatment of Allergic Rhinitis
NCT04976023 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Different Disease Control Indices in Children With Asthma and Rhinitis
NCT00952835 ·Status: UNKNOWN
-
Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory Disorders
NCT00557895 ·Status: TERMINATED